Technical Analysis for RNA - Avidity Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 29.51 | 2.08% | 0.60 |
RNA closed up 2.08 percent on Wednesday, May 15, 2024, on 1.49 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
| Alert | Time |
|---|---|
| Up 5% | about 17 hours ago |
| Up 1 ATR | about 17 hours ago |
| Up 3% | about 17 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
| Up 2% | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 30.54 |
| 52 Week Low | 4.825 |
| Average Volume | 1,129,245 |
| 200-Day Moving Average | 12.74 |
| 50-Day Moving Average | 24.62 |
| 20-Day Moving Average | 25.51 |
| 10-Day Moving Average | 26.73 |
| Average True Range | 1.63 |
| RSI (14) | 68.65 |
| ADX | 20.49 |
| +DI | 34.72 |
| -DI | 13.83 |
| Chandelier Exit (Long, 3 ATRs) | 25.64 |
| Chandelier Exit (Short, 3 ATRs) | 27.14 |
| Upper Bollinger Bands | 28.84 |
| Lower Bollinger Band | 22.19 |
| Percent B (%b) | 1.1 |
| BandWidth | 26.04 |
| MACD Line | 1.14 |
| MACD Signal Line | 0.84 |
| MACD Histogram | 0.2963 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.72 | ||||
| Resistance 3 (R3) | 32.71 | 31.62 | 32.19 | ||
| Resistance 2 (R2) | 31.62 | 30.81 | 31.63 | 32.01 | |
| Resistance 1 (R1) | 30.57 | 30.30 | 31.10 | 30.58 | 31.83 |
| Pivot Point | 29.48 | 29.48 | 29.75 | 29.49 | 29.48 |
| Support 1 (S1) | 28.43 | 28.67 | 28.96 | 28.44 | 27.19 |
| Support 2 (S2) | 27.34 | 28.16 | 27.35 | 27.01 | |
| Support 3 (S3) | 26.29 | 27.34 | 26.84 | ||
| Support 4 (S4) | 26.30 |
